Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Broad-Based Incyte/Merus Collaboration Includes Up To 11 Bispecific Antibody Programs

21 Dec 2016

• By Joseph Haas

Related Content

Merus raises €31m as J&J third corporate VC to invest

03 Oct 2013

Incyte's Oncology Strategy: Putting Its Eggs In Many Mechanistic Baskets

16 May 2016

Related Companies

Incyte Corporation

Merus N.V.

Agenus Inc.

Additional Topics

Commercial Deals ImmunoOncology Business Strategies Companies Platform Technologies Cancer BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.